PDS Biotechnology
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PDSB and other ETFs, options, and stocks.About PDSB
PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its product, PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection.
PDSB Key Statistics
Stock Snapshot
The current PDS Biotechnology(PDSB) stock price is $0.83, with a market capitalization of 45.58M. The stock trades at a price-to-earnings (P/E) ratio of -1.02.
As of 2026-02-01, PDS Biotechnology(PDSB) stock has fluctuated between $0.82 and $0.88. The current price stands at $0.83, placing the stock +0.8% above today's low and -5.6% off the high.
The PDS Biotechnology(PDSB)'s current trading volume is 394.22K, compared to an average daily volume of 859.68K.
During the past year, PDS Biotechnology(PDSB) stock moved between $0.70 at its lowest and $2.20 at its peak.
During the past year, PDS Biotechnology(PDSB) stock moved between $0.70 at its lowest and $2.20 at its peak.
PDSB News
PDS Biotechnology ( (PDSB) ) has issued an announcement. On January 28, 2026, PDS Biotechnology announced that the National Cancer Institute presented prelimin...
PDS Biotechnology (PDSB) announced that results of a National Cancer Institute-led study of the Company’s investigational Interleukin-12 tumor targeted immunocy...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.